Cargando…
Comparable immunoreactivity rates of PD‐L1 in archival and recent specimens from non‐small cell lung cancer
BACKGROUND: Molecular targeted therapy including the use of monoclonal antibodies directed against the immune checkpoints PD‐L1 and PD‐1 receptor have remarkably improved the therapeutic response and survival of cancer patients. The tumor expression level of PD‐L1 can predict the response rate to ch...
Autores principales: | Nakamura, Yuki, Kobayashi, Tetsu, Nishii, Yoichi, Suzuki, Yuta, Saiki, Haruko, Ito, Kentaro, Watanabe, Fumiaki, Nishihama, Kota, Yasuma, Taro, D'Alessandro‐Gabazza, Corina N., Katsuta, Koji, Fujimoto, Hajime, Gabazza, Esteban C, Taguchi, Osamu, Hataji, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209791/ https://www.ncbi.nlm.nih.gov/pubmed/30209885 http://dx.doi.org/10.1111/1759-7714.12861 |
Ejemplares similares
-
Factors leading to failure to diagnose pulmonary malignant tumors using endobronchial ultrasound with guide sheath within the target lesion
por: Nishii, Yoichi, et al.
Publicado: (2019) -
Renal Injury during Long-Term Crizotinib Therapy
por: Yasuma, Taro, et al.
Publicado: (2018) -
Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
por: Hataji, Osamu, et al.
Publicado: (2017) -
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020) -
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
por: Fujiwara, Atsushi, et al.
Publicado: (2018)